{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T05:12:24Z","timestamp":1740633144753,"version":"3.38.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K16332"],"award-info":[{"award-number":["21K16332"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jiac-j.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jiac.2024.08.021","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T04:45:33Z","timestamp":1724993133000},"page":"102506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Daptomycin treatment for persistent bacteremia in a pediatric solid organ transplant recipient: Case report and literature review"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5919-0919","authenticated-orcid":false,"given":"Shota","family":"Myojin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7164-0262","authenticated-orcid":false,"given":"Kensuke","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4799-5562","authenticated-orcid":false,"given":"Jumpei","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiaki","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinari","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seisuke","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mureo","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3886-9089","authenticated-orcid":false,"given":"Isao","family":"Miyairi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jiac.2024.08.021_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkx349","article-title":"Daptomycin","volume":"73","author":"Heidary","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.jiac.2024.08.021_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106770","article-title":"Daptomycin for the treatment of acute bacterial meningitis: a narrative review","volume":"61","author":"Jaber","year":"2023","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"10.1016\/j.jiac.2024.08.021_bib4","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/jac\/dkv368","article-title":"When sepsis persists: a review of MRSA bacteraemia salvage therapy","volume":"71","author":"Kullar","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.jiac.2024.08.021_bib5","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.clinthera.2014.09.005","article-title":"Daptomycin in combination with other antibiotics for the treatment of complicated methicillin-resistant Staphylococcus aureus bacteremia","volume":"36","author":"Dhand","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.jiac.2024.08.021_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14566","article-title":"Optimal liver transplant procedure in progressive familial intrahepatic cholestasis type 1 treated with biliary diversion or intestinal transplantation: lessons learned from three cases treated with different approaches","author":"Uchida","year":"2023","journal-title":"Pediatr Transplant"},{"issue":"1","key":"10.1016\/j.jiac.2024.08.021_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1515\/CCLM.2011.005","article-title":"Determination of daptomycin in human plasma by liquid chromatography-tandem mass spectrometry. Clinical application","volume":"49","author":"Verdier","year":"2011","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"10.1016\/j.jiac.2024.08.021_bib8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/INF.0b013e318160edfc","article-title":"Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections","volume":"27","author":"Abdel-Rahman","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.jiac.2024.08.021_bib9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jiac.2019.08.017","article-title":"Pharmacokinetics and pharmacodynamics of daptomycin in a clinical setting","volume":"26","author":"Tsukada","year":"2020","journal-title":"J Infect Chemother"},{"issue":"1","key":"10.1016\/j.jiac.2024.08.021_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1128\/AAC.48.1.63-68.2004","article-title":"In vivo pharmacodynamic activity of daptomycin","volume":"48","author":"Safdar","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.jiac.2024.08.021_bib11","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"44","key":"10.1016\/j.jiac.2024.08.021_bib12","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","volume":"36","author":"Habib","year":"2015","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jiac.2024.08.021_bib13","first-page":"92","article-title":"The use of daptomycin in the treatment of persistent coagulase-negative staphylococcal sepsis in premature infants: a case series","volume":"26","author":"Asfour","year":"2021","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jiac.2024.08.021_bib14","first-page":"68","article-title":"Methicillin-resistant Staphylococcus aureus endovascular infection in a neonate: prolonged, safe, and effective use of daptomycin and enoxaparin","volume":"25","author":"Chan","year":"2020","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jiac.2024.08.021_bib15","first-page":"61","article-title":"Successful use of daptomycin in a preterm neonate with persistent methicillin-resistant Staphylococcus epidermidis bacteremia","volume":"20","author":"Gawronski","year":"2015","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.jiac.2024.08.021_bib16","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-0672","article-title":"Successful conservative treatment of mycotic pulmonary artery aneurysms caused by MRSA bacteremia","volume":"144","author":"Iki","year":"2019","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.jiac.2024.08.021_bib17","first-page":"490","article-title":"Ceftaroline plus daptomycin for refractory methicillin- resistant Staphylococcus aureus bacteremia in a child","volume":"23","author":"Hall","year":"2018","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jiac.2024.08.021_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02124-16","article-title":"RelA mutant Enterococcus faecium with multiantibiotic tolerance arising in an immunocompromised host","volume":"8","author":"Honsa","year":"2017","journal-title":"mBio"},{"issue":"5","key":"10.1016\/j.jiac.2024.08.021_bib19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/INF.0000000000000958","article-title":"Successful use of high-dose daptomycin in a child with Staphylococcus aureus endocarditis","volume":"35","author":"Prabhudesai","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.jiac.2024.08.021_bib20","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/ped.12700","article-title":"Infective endocarditis associated with acute leukemia: report of two cases","volume":"57","author":"Keino","year":"2015","journal-title":"Pediatr Int"},{"issue":"5","key":"10.1016\/j.jiac.2024.08.021_bib21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1055\/s-0029-1243370","article-title":"Daptomycin use in a neonate: serum level monitoring and outcome","volume":"27","author":"Sarafidis","year":"2010","journal-title":"Am J Perinatol"},{"issue":"5","key":"10.1016\/j.jiac.2024.08.021_bib22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/INF.0b013e3181927891","article-title":"Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia","volume":"28","author":"Jacobson","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2024.08.021_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/IDR.S3649","article-title":"Successful treatment of a neonate with persistent vancomycin-resistant enterococcal bacteremia with a daptomycin-containing regimen","volume":"1","author":"Beneri","year":"2008","journal-title":"Infect Drug Resist"},{"issue":"12","key":"10.1016\/j.jiac.2024.08.021_bib24","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/INF.0b013e31814523f8","article-title":"Daptomycin therapy for invasive Gram-positive bacterial infections in children","volume":"26","author":"Ardura","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.jiac.2024.08.021_bib25","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jiac.2023.02.012","article-title":"Pharmacokinetics of intravenous daptomycin in Japanese pediatric patients: pharmacokinetic comparisons supporting dosing recommendations in Japanese pediatric patients","volume":"29","author":"Ishii","year":"2023","journal-title":"J Infect Chemother"},{"issue":"6","key":"10.1016\/j.jiac.2024.08.021_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02462-17","article-title":"Pharmacokinetics of daptomycin in critically ill pediatric patients","volume":"62","author":"Antachopoulos","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.jiac.2024.08.021_bib27","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/jac\/dku453","article-title":"Daptomycin in paediatrics: current knowledge and the need for future research","volume":"70","author":"Principi","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.jiac.2024.08.021_bib28","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/ajhp\/62.11.1145","article-title":"Daptomycin: a novel cyclic lipopeptide antimicrobial","volume":"62","author":"Schriever","year":"2005","journal-title":"Am J Health Syst Pharm"},{"issue":"12","key":"10.1016\/j.jiac.2024.08.021_bib29","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1086\/652767","article-title":"Daptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditis","volume":"50","author":"Bhavnani","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2024.08.021_bib30","doi-asserted-by":"crossref","first-page":"838599","DOI":"10.3389\/fphar.2022.838599","article-title":"Physiologically based pharmacokinetic modeling of daptomycin dose optimization in pediatric patients with renal impairment","volume":"13","author":"Ye","year":"2022","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.jiac.2024.08.021_bib31","first-page":"117","article-title":"Population pharmacokinetics of daptomycin in critically ill patients with various degrees of renal impairment","volume":"74","author":"Gr\u00e9goire","year":"2019","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24002381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24002381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T06:25:29Z","timestamp":1740551129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X24002381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1341321X24002381"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2024.08.021","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Daptomycin treatment for persistent bacteremia in a pediatric solid organ transplant recipient: Case report and literature review","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2024.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102506"}}